While GLP-1 has proven to be a critical pharmacological tool, with its actions on gastric emptying, appetite suppression, and a preserved insulinotropic effect in T2DM forming the basis of a highly successful class of therapeutics, GIP stands as the dominant physiological incretin in healthy individuals. This evidence concerns the gene GCG and type 2 diabetes mellitus.